CVS Group (4C9) Stock Overview
Engages in veterinary, online pharmacy, and retail businesses in the United Kingdom and Australia. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 2/6 |
| Past Performance | 2/6 |
| Financial Health | 3/6 |
| Dividends | 3/6 |
4C9 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
CVS Group plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | UK£14.00 |
| 52 Week High | UK£17.40 |
| 52 Week Low | UK£9.30 |
| Beta | 1.06 |
| 1 Month Change | 2.94% |
| 3 Month Change | 1.45% |
| 1 Year Change | 23.89% |
| 3 Year Change | -34.58% |
| 5 Year Change | 0% |
| Change since IPO | 328.13% |
Recent News & Updates
Recent updates
Shareholder Returns
| 4C9 | DE Healthcare | DE Market | |
|---|---|---|---|
| 7D | -9.1% | 0.8% | -1.6% |
| 1Y | 23.9% | 39.2% | 13.0% |
Return vs Industry: 4C9 underperformed the German Healthcare industry which returned 39.2% over the past year.
Return vs Market: 4C9 exceeded the German Market which returned 13% over the past year.
Price Volatility
| 4C9 volatility | |
|---|---|
| 4C9 Average Weekly Movement | 6.3% |
| Healthcare Industry Average Movement | 6.6% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in DE Market | 12.4% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 4C9 has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: 4C9's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1999 | 8,850 | Richard William Fairman | www.cvsukltd.co.uk |
CVS Group plc, together with its subsidiaries, engages in veterinary, online pharmacy, and retail businesses in the United Kingdom and Australia. It operates through the Veterinary Practices, Laboratories, and Online Retail Business segments. The company is involved in animal veterinary practices and complementary veterinary diagnostic businesses.
CVS Group plc Fundamentals Summary
| 4C9 fundamental statistics | |
|---|---|
| Market cap | €1.04b |
| Earnings (TTM) | €21.56m |
| Revenue (TTM) | €767.96m |
Is 4C9 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4C9 income statement (TTM) | |
|---|---|
| Revenue | UK£673.20m |
| Cost of Revenue | UK£387.50m |
| Gross Profit | UK£285.70m |
| Other Expenses | UK£266.80m |
| Earnings | UK£18.90m |
Last Reported Earnings
Jun 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.26 |
| Gross Margin | 42.44% |
| Net Profit Margin | 2.81% |
| Debt/Equity Ratio | 48.1% |
How did 4C9 perform over the long term?
See historical performance and comparisonDividends
Does 4C9 pay a reliable dividends?
See 4C9 dividend history and benchmarks| CVS Group dividend dates | |
|---|---|
| Ex Dividend Date | Nov 06 2025 |
| Dividend Pay Date | Dec 05 2025 |
| Days until Ex dividend | 2 days |
| Days until Dividend pay date | 31 days |
Does 4C9 pay a reliable dividends?
See 4C9 dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/11/03 23:30 |
| End of Day Share Price | 2025/11/03 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2025/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
CVS Group plc is covered by 12 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| James Bayliss | Berenberg |
| Allan Smylie | Davy |
| Colin Grant | Davy |